Emergent Biosolutions (EBS) Misses Q3 EPS by 4c

November 1, 2012 7:38 AM

Emergent Biosolutions (NYSE: EBS) reported Q3 EPS of $0.18, $0.04 worse ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found